Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
THERAVANCE INC

THRX

THERAVANCE INC

THERAVANCE INC historical holders

total: 1

Baupost Group THERAVANCE INC transactions over time

Total transactions:
7
New positions:
1
Sold out:
1
Added:
3
Reduced:
2
Held since:
2013 Q2 or earlier
Held for:
11+ quarters
Latest activity:
2016 Q1
Seth Klarman has been an institutional investor in THERAVANCE INC (THRX) since at least 2013 Q2. According to 2026 Q1 report, Seth Klarman doesn't hold any shares. In our earliest available record from 2013 Q2, Baupost Group held about 16.54M shares of THRX. Since at least 2013 Q2, Baupost Group has made 6 more transactions in this position.

When did Seth Klarman exit their THRX position?

Seth Klarman no longer holds THERAVANCE INC (THRX). They sold off their entire position in 2016 Q1, closing out an investment that began in 2013 Q2.

Estimated cost basis*

Weighted AVG buy price:
$38.32
Weighted AVG sell price:
$11.01

THRX transactions history by Baupost Group

7 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2016 Q1
0.00%
$10.54
-100% (-19,815,983)
2014 Q3
5.90%
$17.09
-2.84% (-579,073)
2014 Q2
9.89%
$29.78
-1.50% (-310,745)
2014 Q1
15.49%
$30.94
+2.79% (+561,500)
2013 Q4
20.35%
$35.65
+8.83% (+1,633,930)
2013 Q3
21.62%
$40.87
+11.92% (+1,971,394)
2013 Q2
15.84%
$38.53
new or own*
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.